Recognized standard
QMS24, 3rd Edition September 2016 Replaces GP27-A2 and GP29-A2
FDA recognition 7-139 · CLSI · InVitro Diagnostics
Key facts
| Recognition number | 7-139 |
|---|---|
| Designation | QMS24, 3rd Edition September 2016 Replaces GP27-A2 and GP29-A2 |
| Title | Using Proficiency Testing to Improve the Clinical Laboratory; Approved Guideline - Second Edition |
| Standards developer | Clinical Laboratory Standards Institute |
| Specialty area | InVitro Diagnostics |
| Date of entry | Jan 14, 2019 |
| Scope (excerpt) | This guideline provides assistance to laboratories in using proficiency testing as a quality improvement tool. |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: